NasdaqCM - Delayed Quote USD
Silexion Therapeutics Corp (SLXNW)
0.0367
-0.0331
(-47.42%)
At close: April 24 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
Total Assets
2,863
5,256
9,333
Total Liabilities Net Minority Interest
6,852
17,312
16,412
Total Equity Gross Minority Interest
-3,989
-12,056
-7,079
Total Capitalization
-1,028
-15,476
-10,665
Common Stock Equity
-3,989
-15,476
-10,665
Capital Lease Obligations
526
171
271
Net Tangible Assets
-3,989
-15,476
-10,665
Working Capital
-1,273
2,783
7,229
Invested Capital
-24
-15,476
-10,665
Tangible Book Value
-3,989
-15,476
-10,665
Total Debt
4,491
171
271
Net Debt
2,778
--
--
Share Issued
1,849.1320
905.7380
905.7380
Ordinary Shares Number
1,849.1320
905.7380
905.7380
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SRZNW Surrozen, Inc.
0.0224
+38.27%
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0070
+100.00%
ESLAW Estrella Immunopharma, Inc.
0.0885
+5.11%
BXPHF Botanix Pharmaceuticals Limited
0.2300
0.00%
NLSPW NLS Pharmaceutics AG
0.0040
+2.56%
ABPWW Abpro Holdings, Inc.
0.0239
+18.32%
APLMW Apollomics, Inc.
0.0077
0.00%
KMSTF Kadimastem Ltd
5.06
+690.13%
GSTC GlobeStar Therapeutics Corporation
0.0002
0.00%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0300
0.00%